FARAPULSE Workflow Assessment Registry
← catalyst calendarNCT06656884 · readout in 180 d
Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
524actual
Sites
28
Countries
Austria, Belgium, France +7
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-05-06 | actual | When the study began enrolling |
| Primary completion | 2027-02-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-02-15 | estimated | The whole study's end, after follow-up |
| First posted | 2024-10-24 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Atrial Fibrillation (AF)
Primary outcomes
what the primary-completion date above is the date OFAssociation of patient demographics with Index procedure Workflow-related variables
measured Index Procedure
Association of safety parameters with Index procedure Workflow-related variables
measured 12 months
Association of effectiveness parameters with Index procedure Workflow-related variables
measured 12 months
Association of patient demographics with effectiveness parameters
measured 12 months
Association of patient demographics with safety parameters
measured 12 months
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed